Skip to main content
. 2020 Jun 17;17(12):4349. doi: 10.3390/ijerph17124349

Table 3.

Characteristics of the study and control group considering body composition analysis, control guides and recommendations.

Parameter Group n M ± S.D. Me Min–Max Q1–Q3 p
Body Mass (kg) Study 68 82.4 ± 14.9 81.3 56.7–122.6 69.9–92.5 <0.001
Control 104 72.1 ± 14.5 71.3 16.3–114.1 62.7–80
L.B.M. (kg) Study 68 49.6 ± 7.0 48.9 37.5–64.5 43.8–54.3 0.009
Control 104 46.8 ± 5.8 46.5 35.9–70.1 42.9–50.1
Fat Tissue Mass (kg) Study 68 32.8 ± 9.0 32.2 15.5–58.1 25.9–39.3 <0.001
Control 104 25.9 ± 8.6 24.5 6–57.5 20.2–30.6
S.L.M. (kg) Study 68 45.1 ± 6.4 44.3 33.8–58.9 40.1–49.6 0.018
Control 104 42.7 ± 5.2 42.5 33.3–63.7 39.2–45.6
Minerals (kg) Study 68 4.6 ± 0.8 4.6 3.3–6.8 4–5.2 <0.001
Control 104 4.1 ± 0.7 4 2.6–6.4 3.6–4.5
Protein (kg) Study 68 9.7 ± 3.8 9.1 6.8–38.9 8.3–10.1 0.197
Control 104 9.0 ± 1.0 9.0 7.2–13.2 8.3–9.5
T.B.W. (kg) Study 68 35.3 ± 5.9 35.1 11.1–46.4 31.5–39.2 0.019
Control 104 33.7 ± 4.2 33.5 25.8–50.5 30.9–36.0
P.B.F. (%) Study 68 39.2 ± 5.0 40.3 22.3–47.6 36.7–42.5 <0.001
Control 104 34.9 ± 5.9 35.3 10.2–51.5 32.0–38.9
B.M.I. (kg/m2) Study 68 32.7 ± 5.9 32.6 20.5–50 28.6–35.9 <0.001
Control 104 27.8 ± 5.6 26.9 17.7–53.7 24.2–30.8
Level (steps) Study 68 15.2 ± 3.4 16 3–20 14–17 <0.001
Control 104 12.2 ± 3.9 12 1–20 10–15
V.F.A. (cm2) Study 68 159.9 ± 63.7 156.5 30–316 117–204.8 <0.001
Control 104 111.1 ± 59.5 101 20–386 75–135
A.C. (cm) Study 68 94.5 ± 10.6 93.8 74.1–124.3 86.4–102.1 <0.001
Control 104 86.6 ± 10.4 84.7 62.9–123.6 79.7–91.9
W.H.R. Study 68 0.9 ± 0.1 0.9 0.7–11 0.9–1.0 <0.001
Control 104 0.8 ± 0.1 0.8 0.8–1.1 0.8–0.9
Std. Mc. (kg) Study 68 55.0 ± 7.7 54.9 11.1–77.7 51.8–58.1 <0.001
Control 102 58.1 ± 4.7 58.3 42.4–71.1 55.2–61.1
L. Arm—Adipose Tissue (kg) Study 68 2.1 ± 0.6 2.1 1.0–3.6 1.7–2.6 <0.001
Control 104 1.7 ± 0.5 1.6 0.4–3.6 1.3–2.0
L. Arm—Soft Tissues (kg) Study 68 3.0 ± 0.8 2.8 2.0–8.5 2.6–3.2 0.018
Control 104 2.7 ± 0.4 2.7 2.1–4.4 2.5–3.0
R. Arm—Dipose Tissue (kg) Study 68 2.2 ± 0.6 2.1 1.0–4.2 1.8–2.6 <0.001
Control 104 1.7 ± 0.6 1.6 0.4–3.5 1.3–2.0
R. Arm—Soft Tissues (kg) Study 68 2.9 ± 0.5 2.8 1.9–4.0 2.6–3.2 0.042
Control 104 2.7 ± 0.4 2.7 2.1–4.4 2.5–3.0
Trunk—Adipose Tissue (kg) Study 68 16.8 ± 4.7 16.5 7.0–29.9 13.3–20.2 <0.001
Control 104 13.3 ± 4.4 12.5 3.1–29.6 10.3–15.7
Trunk—Soft Tissues (kg) Study 68 22.4 ± 2.9 22.2 17.4–30.6 20.5–24.5 0.06
Control 104 21.5 ± 2.3 21.4 16.8–29.6 19.8–22.8
L. Leg—Adipose Tissue (kg) Study 68 5.8 ± 1.7 5.8 1.8–10.5 4.6–7.1 <0.001
Control 104 4.7 ± 1.6 4.4 1.1–10.4 3.6–5.5
L. Leg—Soft Tissues (kg) Study 68 8.4 ± 1.5 8.2 6.1–14.1 7.2–9.2 0.017
Control 104 7.8 ± 1.1 7.7 5.9–12.4 7.1–8.5
R. Leg—Adipose Tissue (kg) Study 68 5.9 ± 1.6 5.8 2.7–10.5 4.7–7.0 <0.001
Control 104 4.7 ± 1.5 4.4 1–10.4 3.6–5.5
R. Leg—Soft Tissues (kg) Study 68 8.3 ± 1.3 8.2 6.1–11.2 7.3–9.1 0.013
Control 104 7.9 ± 1.1 7.7 6.0–13.0 7.1–8.5

Mann–Whitney’s Test, L.B.M.—lean body mass (kg); S.L.M.—soft lean mass (kg); T.B.W.—total body water (%); P.B.F.—percent of body fat (%); B.M.I.—Body Mass Index (kg/m2); V.F.A.—visceral fat area (cm2); A.C.—abdominal circumference (cm); W.H.R.—waist hip ratio; Std. Mc.—standard body mass (kg); p—statistical significance level.